NCT00318617View on ClinicalTrials.gov

Effect Of GW501516X On How The Heart Obtains And Uses Energy

TerminatedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2005

Conditions
DyslipidaemiasHeart Failure
Interventions
DRUG

GW510516X

Trial Locations (1)

19104

GSK Investigational Site, Philadelphia

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY